--- title: "Blue Point Laboratories: Potassium Chloride Extended Release 750mg Capsules, ... — FDA announcement Jun 26, 2024 | Is It on Recall" description: "Failed dissolution" url: https://isitonrecall.com/recall/fdapress-e035d833c97c6baa-blue-point-laboratories-potassium-chloride-extended-release-750mg-capsules-100-count-and-500-count/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Recall archive](https://isitonrecall.com/archives/) / FDA company announcement # Blue Point Laboratories: Potassium Chloride Extended Release 750mg Capsules, 100 count and 500 count — FDA announcement Jun 26, 2024 Published notice; closure not supplied A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing. Source date Jun 26, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## What the record says - **Product**: Potassium Chloride Extended Release 750mg Capsules, 100 count and 500 count - **Reason**: Failed dissolution - **Classification**: Not supplied - **Recalling firm**: American Health Packaging - **Quantity**: Not supplied - **Agency-reported status**: Company recall announcement - **Source record identifier**: e035d833c97c6baa [Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-health-packaging-behalf-bluepoint-laboratories-issues-voluntary-nationwide-recall-potassium) ## Lot and product identifiers | Label field | Details supplied by the agency | | --- | --- | | Lot, code or applicability | The recall includes the lot numbers and expiration dates listed below:; Sr. No \| NDC \| Product Name \| Batch No. \| Expiry Date; 1. \| 68001-396-00 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 100 count \| 17221738 \| 07/31/2024; 2. \| 68001-396-00 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 100 count \| 17222494 \| 10/31/2024; 3. \| 68001-396-00 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 100 count \| 17230533 \| 01/31/2025; 4. \| 68001-396-00 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 100 count \| 17232208 \| 09/30/2025; 5. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17221823 \| 07/31/2024; 6. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17221830 \| 07/31/2024; 7. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17221831 \| 08/31/2024; 8. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17230248 \| 12/31/2024; 9. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17230253 \| 12/31/2024; 10. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17230271 \| 12/31/2024; 11. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17230796 \| 02/28/2025; 12. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17230820 \| 02/28/2025; 13. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17230825 \| 03/31/2025; 14. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17230833 \| 03/31/2025; 15. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17230840 \| 03/31/2025; 16. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17231537 \| 06/30/2025; 17. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 50 count \| 17231540 \| 06/30/2025; 18. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17231719 \| 06/30/2025; 19. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17231737 \| 06/30/2025; 20. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count \| 17232111 \| 09/30/2025; 21. \| 68001-396-03 \| Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 50 count \| 17232164 \| 09/30/2025 | Match all identifying details in the current notice. A brand name alone is not enough. ## Product tables from the announcement These identifying details come from the company announcement posted by FDA. Check the current notice for revisions. **FDA company announcement, table 1** | Sr. No | NDC | Product Name | Batch No. | Expiry Date | | --- | --- | --- | --- | --- | | 1. | 68001-396-00 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 100 count | 17221738 | 07/31/2024 | | 2. | 68001-396-00 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 100 count | 17222494 | 10/31/2024 | | 3. | 68001-396-00 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 100 count | 17230533 | 01/31/2025 | | 4. | 68001-396-00 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 100 count | 17232208 | 09/30/2025 | | 5. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17221823 | 07/31/2024 | | 6. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17221830 | 07/31/2024 | | 7. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17221831 | 08/31/2024 | | 8. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17230248 | 12/31/2024 | | 9. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17230253 | 12/31/2024 | | 10. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17230271 | 12/31/2024 | | 11. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17230796 | 02/28/2025 | | 12. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17230820 | 02/28/2025 | | 13. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17230825 | 03/31/2025 | | 14. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17230833 | 03/31/2025 | | 15. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17230840 | 03/31/2025 | | 16. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17231537 | 06/30/2025 | | 17. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 50 count | 17231540 | 06/30/2025 | | 18. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17231719 | 06/30/2025 | | 19. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17231737 | 06/30/2025 | | 20. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 500 count | 17232111 | 09/30/2025 | | 21. | 68001-396-03 | Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEQ K – 50 count | 17232164 | 09/30/2025 | Announcement retrieved Oct 1, 2026. [Official announcement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-health-packaging-behalf-bluepoint-laboratories-issues-voluntary-nationwide-recall-potassium). ## Distribution Not supplied No US distribution state could be established from this record. Check the official notice. ## Dates in the source - **Fda listing date**: Jun 26, 2024 - **Company announcement date**: Jun 25, 2024 FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable. ## What to do next Consumers that have Potassium Chloride Extended-Release Capsules subject to the recall should consult with their physician or health care provider before they stop using the product. Consumers should also contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Consumers should call Sedgwick, a recall solution vendor, at 1- 855-695-8564, Monday - Friday, 8:00 am – 5:00 pm EST for return instructions and further information. [Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/american-health-packaging-behalf-bluepoint-laboratories-issues-voluntary-nationwide-recall-potassium) ## Before changing a medicine Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine. Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do) ## Related records [Medications records](https://isitonrecall.com/category/medications/) [American Health Packaging records](https://isitonrecall.com/brand/american-health-packaging/)